Namgoong-gyeon, chairman of Mirae I&G, will move on to a new business by taking over Humasis, a company specializing in in vitro diagnostics, which has recently been the victim of a dispute over control rights.
On the 30th, CEO Namgung-gyeon announced the acquisition of Humasis, a company specializing in in vitro diagnostic kits, through Artist Cosmetics. Artist Cosmetics decided to acquire 2,593,814 shares of Humasis anew at 65 billion won to secure management rights through the acquisition of shares. Upon completion of the contract, Artist Cosmetics will secure a 7.65% stake in Humasis and become the largest shareholder.
The company expects that it will be possible to pursue a stable business after the acquisition as the management rights dispute filed at the recent meeting of Humasis minority shareholders has been resolved. A company official explained, “All disputes with minority shareholder meetings in Humasis have been cancelled.
Chairman Namgung-gyeon said, “We will focus on the in vitro diagnostic kit business, which is the main business of Humasis, and strengthen our capabilities such as product development and market development. Since all management uncertainties have been resolved, we will doing our best to enter new businesses based on solid business,” he said.
